東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ null ]

切換: 標籤 | MARC模式 | ISBD

Using Multimodal AI to Predict Lung ...

Ding, Ruiwen,

FindBook

Google Book

Amazon

博客來

Using Multimodal AI to Predict Lung Adenocarcinoma Recurrence /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Using Multimodal AI to Predict Lung Adenocarcinoma Recurrence // Ruiwen Ding.
作者:	Ding, Ruiwen,
面頁冊數:	1 electronic resource (166 pages)
附註:	Source: Dissertations Abstracts International, Volume: 86-12, Section: B.
Contained By:	Dissertations Abstracts International86-12B.
標題:	Bioengineering. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=32046688
ISBN:	9798315793052

Using Multimodal AI to Predict Lung Adenocarcinoma Recurrence /
Ding, Ruiwen,

Using Multimodal AI to Predict Lung Adenocarcinoma Recurrence /Ruiwen Ding. - 1 electronic resource (166 pages)

Source: Dissertations Abstracts International, Volume: 86-12, Section: B.

Lung adenocarcinoma (LUAD), a subtype of non-small cell lung cancer (NSCLC), is characterized by significant histologic and clinical heterogeneity. Although early-stage NSCLC patients are commonly treated with curative resection, a substantial proportion experience recurrence within five years. Current prognostic tools such as tumor, node, and metastasis staging fail to fully capture tumor aggressiveness for patients with different characteristics. This underscores the need for more accurate, LUAD-specific risk stratification approaches. Recent advances in artificial intelligence (AI) and machine learning (ML) offer new opportunities to derive prognostic biomarkers from routinely acquired data such as radiological scans and histopathology tissue slides. However, existing pathomic models often overlook the spatial context within the tissue slides, and most of them do not explicitly consider different NSCLC subtypes. Furthermore, most AI/ML models rely on unimodal data, missing the complementary insights available from various data modalities. This dissertation addresses these limitations by developing novel AI/ML-based methods to predict cancer aggressiveness in early-stage LUAD patients, using various data modalities such as hematoxylin & eosin-stained whole slide images, preoperative computed tomography scans, and clinical information. The proposed framework captures tumor heterogeneity through spatially-aware pathomic features and integrates different data modalities to improve risk stratification. In doing so, this work aims to improve personalized risk prediction and inform adjuvant therapy decisions by adding additional evidence on top of the standard clinical assessments.

English

ISBN: 9798315793052Subjects--Topical Terms:

657580
Bioengineering.
Subjects--Index Terms:

Digital pathology

Using Multimodal AI to Predict Lung Adenocarcinoma Recurrence /
LDR:03141nmm a22004333i 4500 001 2432732
005 20250731101921.5
006 m o d
007 cr|nu||||||||
008 261011s2025 miu||||||m |||||||eng d
020 $a 9798315793052
035 $a (MiAaPQD)AAI32046688
035 $a AAI32046688
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Ding, Ruiwen, $e author. $3 3822069
245 1 0 $a Using Multimodal AI to Predict Lung Adenocarcinoma Recurrence / $c Ruiwen Ding.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2025
300 $a 1 electronic resource (166 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-12, Section: B.
500 $a Advisors: Hsu, William Committee members: Aberle, Denise R.; Bui, Alex Anh-Tuan; Arnold, Corey.
502 $b Ph.D. $c University of California, Los Angeles $d 2025.
520 $a Lung adenocarcinoma (LUAD), a subtype of non-small cell lung cancer (NSCLC), is characterized by significant histologic and clinical heterogeneity. Although early-stage NSCLC patients are commonly treated with curative resection, a substantial proportion experience recurrence within five years. Current prognostic tools such as tumor, node, and metastasis staging fail to fully capture tumor aggressiveness for patients with different characteristics. This underscores the need for more accurate, LUAD-specific risk stratification approaches. Recent advances in artificial intelligence (AI) and machine learning (ML) offer new opportunities to derive prognostic biomarkers from routinely acquired data such as radiological scans and histopathology tissue slides. However, existing pathomic models often overlook the spatial context within the tissue slides, and most of them do not explicitly consider different NSCLC subtypes. Furthermore, most AI/ML models rely on unimodal data, missing the complementary insights available from various data modalities. This dissertation addresses these limitations by developing novel AI/ML-based methods to predict cancer aggressiveness in early-stage LUAD patients, using various data modalities such as hematoxylin & eosin-stained whole slide images, preoperative computed tomography scans, and clinical information. The proposed framework captures tumor heterogeneity through spatially-aware pathomic features and integrates different data modalities to improve risk stratification. In doing so, this work aims to improve personalized risk prediction and inform adjuvant therapy decisions by adding additional evidence on top of the standard clinical assessments.
546 $a English
590 $a School code: 0031
650 4 $a Bioengineering. $3 657580
650 4 $a Medical imaging. $3 3172799
650 4 $a Oncology. $3 751006
653 $a Digital pathology
653 $a Lung cancer
653 $a Multimodal data fusion
653 $a Recurrence prediction
690 $a 0202
690 $a 0574
690 $a 0992
690 $a 0800
710 2 $a University of California, Los Angeles. $b Bioengineering 0288. $e degree granting institution. $3 3822070
720 1 $a Hsu, William $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-12B.
790 $a 0031
791 $a Ph.D.
792 $a 2025
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=32046688